The teratogenic effects of imatinib mesylate on rat fetuses

Imatinib mesylate, a selective tyrosine kinase inhibitor, is the first line treatment against chronic myelogenous leukemia and gastrointestinal stromal tumors. The aim of the present study is to investigate the effects of imatinib mesylate on the pregnant rats and their fetuses. Pregnant rats were d...

Full description

Bibliographic Details
Main Authors: M.M. El Gendy, A.M. Kandil, M.A. Helal, F.M. Zahou
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750015000529